← Open Payments lookup

LYSA DEL GROSSO: Open Payments

NPI 1578089215 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,110 in 121 payments from 11 companies in 2025. Trend: 2023 $2,088 · 2024 $2,159 · 2025 $2,110

Food & beverage: $2,110
CompanyPaymentsAmount
ABBVIE INC.32$424
Neurocrine BioSciences, Inc.22$404
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$290
E.R. Squibb & Sons, L.L.C.12$239
Teva Pharmaceuticals USA, Inc.17$216
Janssen Pharmaceuticals, Inc3$197
Alkermes, Inc.10$154
Otsuka America Pharmaceutical, Inc.7$137
Supernus Pharmaceuticals, Inc.1$18
Lundbeck LLC1$15

Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, INVEGA SUSTENNA, UZEDY, ARISTADA, REXULTI.

Industry payments across SC — which companies pay providers there.